EcoDrugPlus

Ensembl ID : ML003233a
Gene Symbol: -
External references: -
278 Possible Orthologues:

Ensembl ID : ML003272a
Gene Symbol: -
External references: -
65 Possible Orthologues:

Ensembl ID : ML00365a
Gene Symbol: -
External references: -
201 Possible Orthologues:

Ensembl ID : ML00441a
Gene Symbol: -
External references: -
461 Possible Orthologues:

Ensembl ID : ML004443a
Gene Symbol: -
External references: -
327 Possible Orthologues:

Ensembl ID : ML004510a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML00482a
Gene Symbol: -
External references: -
450 Possible Orthologues:

Ensembl ID : ML005015a
Gene Symbol: -
External references: -
217 Possible Orthologues:

Ensembl ID : ML005021a
Gene Symbol: -
External references: -
81 Possible Orthologues:

Ensembl ID : ML005023a
Gene Symbol: -
External references: -
1356 Possible Orthologues:

Ensembl ID : ML005024a
Gene Symbol: -
External references: -
81 Possible Orthologues:

Ensembl ID : ML050915a
Gene Symbol: -
External references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).